Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-063840
Filing Date
2025-05-05
Accepted
2025-05-05 20:35:34
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7049
  Complete submission text file 0000950170-25-063840.txt   8599
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Issuer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Quinn William P. (Reporting) CIK: 0001724190 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39988 | Film No.: 25914786